Natco dares Novartis with new heart drug

According to data from AIOCD PharmaTrac, an agency that closely tracks pharmaceutical sales, Vymada had sales of Rs 68.3 crore for December 2018 on the moving annual turnover (MAT).

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2WtyAVR
via IFTTT